News

10/17/2017 Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
09/22/2017 Avista Capital Partners to Acquire Miraca Life Sciences
09/18/2017 Optinose Announces FDA Approval of XHANCE™ (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps
08/01/2017 WOW! To Sell Chicago Fiber Network to Verizon
06/28/2017 Trimb acquires well-established OTC products in Europe
06/16/2017 WOW! Announces Commitments for $2.28 Billion of New Term Loans
06/14/2017 Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock
06/06/2017 Avista and Nordic Capital close placing of 250 million ordinary shares in ConvaTec Group Plc
06/05/2017 Avista Capital Partners has Acquired National Spine & Pain Centers
05/24/2017 WOW! Anounces Pricing of Initial Public Offering
05/09/2017 OptiNose Raises $37 Million in Series D Funding Led by Fidelity
05/05/2017 VWR Enters into Definitive Agreement with Avantor
05/03/2017 Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock
04/06/2017 AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
03/28/2017 Avista and Nordic Capital announce the proposed sale of a 19.95% shareholding in ConvaTec Group Plc to Novo A/S (the investment holding company of the Novo Nordisk Foundation) and a proposed placing of approximately 300 million ordinary shares
03/13/2017 Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders
02/28/2017 Acino to acquire Litha Healthcare in South Africa
02/24/2017 Hi-Crush Partners LP Announces Pricing of Primary Offering of Common Units
02/23/2017 Hi-Crush Partners LP Announces Acquisition of Permian Basin Sand, Acquisition of Whitehall Facility and Remaining Interest in Augusta Facility
01/31/2017 OptiNose Announces FDA Acceptance for Filing of the New Drug Application for OPN-375
11/15/2016 Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock
11/14/2016 AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders

© 2017 Avista Capital Partners.